Abstract
Despite enormous therapeutic advances, cardiovascular disease remains a global public health problem. There is substantial interest in identifying new risk factors, to improve our understanding of disease biology and to account for the cases of heart disease that cannot be explained by known risk factors (smoking, diabetes, hypertension, obesity and history of coronary heart disease). Investigation of putative risk factors frequently involves the study of circulating biomarkers. Prior to the transfer from bench to bedside, these cardiovascular risk biomarkers have to meet the following requirements: 1) Can the clinician measure the biomarker?; 2) Does the biomarker add new information?; 3) Will the biomarker help the clinician manage patients? Until now, only few biomarkers have satisfactorily fulfilled these requirements.
| Original language | Italian |
|---|---|
| Pages (from-to) | 240-244 |
| Number of pages | 5 |
| Journal | Giornale di Gerontologia |
| Volume | 57 |
| Issue number | 5 |
| Publication status | Published - Oct 2009 |
Fingerprint
ASJC Scopus subject areas
- Ageing
- Geriatrics and Gerontology
Cite this
Biomarcatori di rischio cardiovascolare. / Marchegiani, Francesca; Provinciali, M.; Lattanzio, F.
In: Giornale di Gerontologia, Vol. 57, No. 5, 10.2009, p. 240-244.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Biomarcatori di rischio cardiovascolare
AU - Marchegiani, Francesca
AU - Provinciali, M.
AU - Lattanzio, F.
PY - 2009/10
Y1 - 2009/10
N2 - Despite enormous therapeutic advances, cardiovascular disease remains a global public health problem. There is substantial interest in identifying new risk factors, to improve our understanding of disease biology and to account for the cases of heart disease that cannot be explained by known risk factors (smoking, diabetes, hypertension, obesity and history of coronary heart disease). Investigation of putative risk factors frequently involves the study of circulating biomarkers. Prior to the transfer from bench to bedside, these cardiovascular risk biomarkers have to meet the following requirements: 1) Can the clinician measure the biomarker?; 2) Does the biomarker add new information?; 3) Will the biomarker help the clinician manage patients? Until now, only few biomarkers have satisfactorily fulfilled these requirements.
AB - Despite enormous therapeutic advances, cardiovascular disease remains a global public health problem. There is substantial interest in identifying new risk factors, to improve our understanding of disease biology and to account for the cases of heart disease that cannot be explained by known risk factors (smoking, diabetes, hypertension, obesity and history of coronary heart disease). Investigation of putative risk factors frequently involves the study of circulating biomarkers. Prior to the transfer from bench to bedside, these cardiovascular risk biomarkers have to meet the following requirements: 1) Can the clinician measure the biomarker?; 2) Does the biomarker add new information?; 3) Will the biomarker help the clinician manage patients? Until now, only few biomarkers have satisfactorily fulfilled these requirements.
KW - Acute coronary syndrome
KW - Biomarker
KW - Genetics
UR - http://www.scopus.com/inward/record.url?scp=75349095440&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=75349095440&partnerID=8YFLogxK
M3 - Articolo
AN - SCOPUS:75349095440
VL - 57
SP - 240
EP - 244
JO - Giornale di Gerontologia
JF - Giornale di Gerontologia
SN - 0017-0305
IS - 5
ER -